These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29672567)

  • 1. Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.
    Wu WC; Taveira TH; Jeffery S; Jiang L; Tokuda L; Musial J; Cohen LB; Uhrle F
    PLoS One; 2018; 13(4):e0195898. PubMed ID: 29672567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.
    Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC
    Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes.
    Cohen LB; Taveira TH; Khatana SA; Dooley AG; Pirraglia PA; Wu WC
    Diabetes Educ; 2011; 37(6):801-12. PubMed ID: 22021025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
    Sherrill CH; Pentecost A; Wood EE
    J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
    Kirwin JL; Cunningham RJ; Sequist TD
    J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
    Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
    J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Pharmacoeconomic Model to Demonstrate the Effect of Clinical Pharmacist Involvement in Diabetes Management.
    Ourth H; Nelson J; Spoutz P; Morreale AP
    J Manag Care Spec Pharm; 2018 May; 24(5):449-457. PubMed ID: 29694293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
    Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial.
    Obreli-Neto PR; Marusic S; Guidoni CM; Baldoni Ade O; Renovato RD; Pilger D; Cuman RK; Pereira LR
    J Manag Care Spec Pharm; 2015 Jan; 21(1):66-75. PubMed ID: 25562774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-led group medical appointment model in type 2 diabetes.
    Taveira TH; Friedmann PD; Cohen LB; Dooley AG; Khatana SA; Pirraglia PA; Wu WC
    Diabetes Educ; 2010; 36(1):109-17. PubMed ID: 19966072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial.
    Siaw MYL; Malone DC; Ko Y; Lee JY
    J Clin Pharm Ther; 2018 Dec; 43(6):775-783. PubMed ID: 29696669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.